Antje Blank (A Blank)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

Plasmodium Falciparum

Monoclonal Antibody

Top Venues

Clinical pharmacokinetics

Clinical and translational science

Cardiovascular drugs and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Brit S Rohr, Evelyn Krohmer, Kathrin I Foerster, Juergen Burhenne, Martin Schulz, Antje Blank, Gerd Mikus, Walter Emil Haefeli
Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers. Clinical pharmacokinetics 63 (4) (2024)
Nicolas Hohmann, Anna S Friedrichs, Juergen Burhenne, Antje Blank, Gerd Mikus, Walter Emil Haefeli
Dose-dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin. Clinical and translational science 17 (8) (2024)
Nicolas Hohmann, Anna S Friedrichs, Juergen Burhenne, Antje Blank, Gerd Mikus, Walter Emil Haefeli
Dose-dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin. Clinical and translational science 17 (8) (2024)
Brit S Rohr, Evelyn Krohmer, Kathrin I Foerster, Juergen Burhenne, Martin Schulz, Antje Blank, Gerd Mikus, Walter Emil Haefeli
Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers. Clinical pharmacokinetics 63 (4) (2024)
Brit S Rohr, Evelyn Krohmer, Kathrin I Foerster, Juergen Burhenne, Martin Schulz, Antje Blank, Gerd Mikus, Walter Emil Haefeli
Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers. Clinical pharmacokinetics 63 (4) (2024)
Brit S Rohr, Evelyn Krohmer, Kathrin I Foerster, Juergen Burhenne, Martin Schulz, Antje Blank, Gerd Mikus, Walter Emil Haefeli
Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers. Clinical pharmacokinetics 63 (4) (2024)
Brit S Rohr, Evelyn Krohmer, Kathrin I Foerster, Juergen Burhenne, Martin Schulz, Antje Blank, Gerd Mikus, Walter Emil Haefeli
Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers. Clinical pharmacokinetics (2024)
Amin Muhareb, Antje Blank, Andreas Daniel Meid, Kathrin I Foerster, Felicitas Stoll, Juergen Burhenne, Walter Emil Haefeli, Gerd Mikus
CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults. Clinical pharmacokinetics (2023)
Alexander Lenard, Simon A Hermann, Felicitas Stoll, Juergen Burhenne, Kathrin I Foerster, Gerd Mikus, Andreas D Meid, Walter E Haefeli, Antje Blank
Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach. Cardiovascular drugs and therapy (2023)
Micha Rosenkranz, Kristin Fürle, Julia Hibbert, Anne Ulmer, Arin Ali, Thomas Giese, Antje Blank, Walter E Haefeli, Ernst Böhnlein, Michael Lanzer, Richard Thomson-Luque
Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine. NPJ vaccines 8 (1) (2023)
Evelyn Krohmer, Brit Silja Rohr, Felicitas Stoll, Katja S Gümüs, Mariano Bergamino, Gerd Mikus, Max Sauter, Juergen Burhenne, Johanna Weiss, Andreas Daniel Meid, David Czock, Antje Blank, Walter Emil Haefeli
Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin. Cardiovascular drugs and therapy (2023)
Antje Blank, Nicolas Hohmann, Marlen Dettmer, Anette Manka-Stuhlik, Gerd Mikus, Felicitas Stoll, Marlies Stützle-Schnetz, Daniel Thomas, Evelyn Exner, Beate Schmitt-Bormann, Torsten Schaller, Rico Laage, Oliver Schönborn-Kellenberger, Michaela Arndt, Walter Emil Haefeli, Jürgen Krauss
First-in-human, randomized, double-blind, placebo-controlled, dose escalation trial of the anti-herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers. Clinical and translational science 15 (10) (2022)
Antje Blank, Kristin Fürle, Anja Jäschke, Gerd Mikus, Monika Lehmann, Johannes Hüsing, Kirsten Heiss, Thomas Giese, Darrick Carter, Ernst Böhnlein, Michael Lanzer, Walter E Haefeli, Hermann Bujard
Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial. NPJ vaccines 5 (1) (2020)
Felicitas Stoll, Antje Blank, Gerd Mikus, David Czock, Kathrin I Foerster, Simon Hermann, Katja Häußler, Amin Muhareb, Simone Hummler, Johanna Weiss, Jürgen Burhenne, Walter E Haefeli
Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial. Trials 21 (1) (2020)
Nicolas Hohmann, Antje Blank, Jürgen Burhenne, Yosuke Suzuki, Gerd Mikus, Walter Emil Haefeli
Simultaneous phenotyping of CYP2E1 and CYP3A using oral chlorzoxazone and midazolam microdoses. British journal of clinical pharmacology 85 (10) (2019)
Antje Blank, A Eidam, M Haag, N Hohmann, J Burhenne, M Schwab, Sfj van de Graaf, M R Meyer, Hans H Maurer, K Meier, J Weiss, T Bruckner, A Alexandrov, S Urban, G Mikus, W E Haefeli
The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics. Clinical pharmacology and therapeutics 103 (2) (2017)
Davor Slijepcevic, Reinout L P Roscam Abbing, Takeshi Katafuchi, Antje Blank, Joanne M Donkers, Stéphanie van Hoppe, Dirk R de Waart, Dagmar Tolenaars, Jonathan H M van der Meer, Manon Wildenberg, Ulrich Beuers, Ronald P J Oude Elferink, Alfred H Schinkel, Stan F J van de Graaf
Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice. Hepatology (Baltimore, Md.) 66 (5) (2017)